BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8195838)

  • 1. Trimethoprim and brodimoprim resistance of gram-positive and gram-negative bacteria.
    Thomson CJ
    J Chemother; 1993 Dec; 5(6):458-64. PubMed ID: 8195838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative antibacterial spectrum of trimethoprim and brodimoprim.
    Amyes SG
    J Chemother; 1993 Dec; 5(6):417-21. PubMed ID: 8195832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid-mediated trimethoprim-resistance in Staphylococcus aureus. Characterization of the first gram-positive plasmid dihydrofolate reductase (type S1).
    Young HK; Skurray RA; Amyes SG
    Biochem J; 1987 Apr; 243(1):309-12. PubMed ID: 3606580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neisseriaceae, a group of bacteria with dihydrofolate reductases, moderately susceptible to trimethoprim.
    Then RL
    Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):450-8. PubMed ID: 44939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. dfrA20, A novel trimethoprim resistance gene from Pasteurella multocida.
    Kehrenberg C; Schwarz S
    Antimicrob Agents Chemother; 2005 Jan; 49(1):414-7. PubMed ID: 15616323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brodimoprim, a new bacterial dihydrofolate reductase inhibitor: a minireview.
    Periti P
    J Chemother; 1995 Jun; 7(3):221-3. PubMed ID: 7562018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and cloning of the type IIIa plasmid-encoded dihydrofolate reductase gene from trimethoprim-resistant gram-negative bacteria isolated in Britain.
    Thomson CJ; Towner KJ; Young HK; Amyes SG
    J Med Microbiol; 1990 Mar; 31(3):213-8. PubMed ID: 2179557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The type VII dihydrofolate reductase: a novel plasmid-encoded trimethoprim-resistant enzyme from gram-negative bacteria isolated in Britain.
    Amyes SG; Towner KJ; Carter GI; Thomson CJ; Young HK
    J Antimicrob Chemother; 1989 Aug; 24(2):111-9. PubMed ID: 2676936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational 'hot-spots' in mammalian, bacterial and protozoal dihydrofolate reductases associated with antifolate resistance: sequence and structural comparison.
    Volpato JP; Pelletier JN
    Drug Resist Updat; 2009; 12(1-2):28-41. PubMed ID: 19272832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of the novel diaminopyrimidine, iclaprim, in combination with folate inhibitors and other antimicrobials with different mechanisms of action.
    Laue H; Weiss L; Bernardi A; Hawser S; Lociuro S; Islam K
    J Antimicrob Chemother; 2007 Dec; 60(6):1391-4. PubMed ID: 17962215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of resistance to diaminopyrimidines.
    Goldstein FW; Acar JF
    J Chemother; 1993 Dec; 5(6):453-7. PubMed ID: 8195837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative topography of the catalytic sites of chromosomal dihydrofolate reductases and that of the enzyme encoded in R 67 plasmid from E. coli].
    Tu YX; Lebrun E; Bon F; Liu ZJ; Van Rapenbusch R
    C R Acad Sci III; 1988; 306(13):385-90. PubMed ID: 3136866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of thymine starvation in the expression of type IV plasmid-encoded trimethoprim-resistant dihydrofolate reductase.
    Thomson CJ; Young HK; Amyes SG
    J Med Microbiol; 1993 Apr; 38(4):250-5. PubMed ID: 8474116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal amino acid sequence of the novel type IIIb trimethoprim-resistant plasmid-encoded dihydrofolate reductase from Shigella sonnei.
    Thomson CJ; Barg N; Amyes SG
    J Gen Microbiol; 1990 Apr; 136(4):673-7. PubMed ID: 2204677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethoprim resistance transposon Tn4003 from Staphylococcus aureus encodes genes for a dihydrofolate reductase and thymidylate synthetase flanked by three copies of IS257.
    Rouch DA; Messerotti LJ; Loo LS; Jackson CA; Skurray RA
    Mol Microbiol; 1989 Feb; 3(2):161-75. PubMed ID: 2548057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of brodimoprim as an inhibitor of dihydrofolate reductases.
    Then RL; Hermann F
    Chemotherapy; 1984; 30(1):18-25. PubMed ID: 6363003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards the understanding of resistance mechanisms in clinically isolated trimethoprim-resistant, methicillin-resistant Staphylococcus aureus dihydrofolate reductase.
    Frey KM; Lombardo MN; Wright DL; Anderson AC
    J Struct Biol; 2010 Apr; 170(1):93-7. PubMed ID: 20026215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iclaprim, a novel diaminopyrimidine for the treatment of resistant gram-positive infections.
    Sincak CA; Schmidt JM
    Ann Pharmacother; 2009 Jun; 43(6):1107-14. PubMed ID: 19435963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the mechanisms of resistance to trimethoprim in Salmonella typhimurium].
    Hu Y
    Wei Sheng Wu Xue Bao; 1993 Jun; 33(3):219-26. PubMed ID: 8236954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.